<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><label>Table 1.</label><caption><title>Features of mouse models used in this study.</title><p>Characteristics of DYT1 dystonia mouse models including extent of Cre field, behavioral phenotype, and neuropathological phenotype.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Model</th><th>Genotype</th><th><italic>Cre</italic> field</th><th>Organismal/behavioral phenotype</th><th>Histologic findings</th><th>Rationale for use</th><th>Impact of torsinB modulation</th></tr></thead><tbody><tr><td>Emx1(A)-CKO</td><td><italic>Emx1-Cre; Tor1a<sup>KO/flx</sup></italic></td><td>Forebrain excitatory, prominent in cortex and hippocampus</td><td>Normal appearing <break/>Limb clasping in a subset of mice</td><td>Forebrain-selective neurodegeneration</td><td>Forebrain motor loop involvement <break/>Mild behavioral and neuropathology findings to assess combined torsinA and B LOF</td><td><bold>Reduction:</bold> <break/>Worsened neuropathology and behavior</td></tr><tr><td>Emx1-SKI</td><td><italic>Emx1-Cre; Tor1a<sup>&#916;E/flx</sup></italic></td><td>Forebrain excitatory, prominent in cortex and hippocampus</td><td>Normal appearing <break/>Limb clasping in a subset of mice</td><td>Forebrain-selective neurodegeneration milder than that seen in Emx1-CKO</td><td>Forebrain motor loop involvement <break/>Presence of disease mutant torsinA</td><td><bold>Reduction:</bold> <break/>Dose-dependent worsening of neuropathology and behavior</td></tr><tr><td>Nes(A)-CKO</td><td><italic>Nestin-Cre; Tor1a<sup>KO/flx</sup></italic></td><td>Entire nervous system</td><td>Lack of postnatal weight gain <break/>Early lethality by 3rd postnatal week <break/>Overtly abnormal postures at rest</td><td>Degeneration in multiple sensorimotor regions</td><td>Clear and robust phenotypes <break/>Widespread involvement of nervous system</td><td><bold>Overexpression:</bold> <break/>Prevention of lethality, restored weight gain <break/>Prevention of degeneration and gliosis</td></tr><tr><td>Nes-SKI</td><td><italic>Nestin-Cre; Tor1a<sup>&#916;E/flx</sup></italic></td><td>Entire nervous system</td><td>Reduced postnatal weight gain <break/>Overt postural and developmental phenotypes at rest</td><td>Degeneration in multiple sensorimotor regions</td><td>Widespread involvement of nervous system <break/>Presence of disease mutant torsinA</td><td><bold>Overexpression:</bold> <break/>Restored weight gain <break/>Prevention of degeneration and gliosis</td></tr><tr><td>Dlx(A)-CKO</td><td><italic>Dlx5/6-Cre; Tor1a<sup>KO/flx</sup></italic></td><td>Forebrain GABAergic and cholinergic, including all striatal neurons</td><td>Limb clasping and trunk twisting; symptoms respond to drugs used in human patients</td><td>Selective degeneration of dorsal striatal cholinergic interneurons</td><td>Predictive validity <break/>Time course of motor abnormalities mimics that of human patients</td><td><bold>Overexpression:</bold> <break/>Prevention of abnormal limb clasping and twisting movements <break/>Prevention of cholinergic interneuron degeneration</td></tr></tbody></table></table-wrap>